American Cancer Society. Cancer facts & figures 2022. Atlanta, Ga: American Cancer Society; 2022. https://doi.org/10.3238/arztebl.2008.0255.

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131:2745–60.

Article  CAS  PubMed  Google Scholar 

Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3:16096.

Article  PubMed  PubMed Central  Google Scholar 

Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS, et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014:41–51.

Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45:868–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun. 2017;8:14175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun. 2016;7:10933.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coombs CC, Rassenti LZ, Falchi L, Slager SL, Strom SS, Ferrajoli A, et al. Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans patients ascertained at Duke University. Blood. 2012;120:1687–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 2022;36:2835–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

National Cancer Institute. SEER Cancer stat facts: leukemia—chronic lymphocytic leukemia (CLL). 2022. https://seer.cancer.gov/statfacts/html/clyl.html.

Zhao Y, Wang Y, Ma S. Racial differences in four leukemia subtypes: comprehensive descriptive epidemiology. Sci Rep. 2018;8:548.

Article  PubMed  PubMed Central  Google Scholar 

Ayers AA, Lyu L, Dance K, Ward KC, Flowers CR, Koff JL, et al. Characterizing lymphoma incidence and disparities for a cancer center catchment region. Clin Lymphoma Myeloma Leuk. 2019;19:699–708.

Article  PubMed  PubMed Central  Google Scholar 

Kittai AS, Huang Y, Bhat SA, Paskett ED, Rogers KA, Barrientos JC, et al. Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019. Blood Adv. 2023;7:2575–9.

Article  PubMed  Google Scholar 

Vardell VA, Ermann DA, Fitzgerald LA, Shah HR, Hu B, Stephens DM. Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. Am J Hematol. 2023;98:E172–E174.

Article  PubMed  Google Scholar 

Falchi L, Keating MJ, Wang X, Coombs CC, Lanasa MC, Strom S, et al. Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia. Cancer. 2013;119:3177–85.

Article  CAS  PubMed  Google Scholar 

Coombs CC, Falchi L, Weinberg JB, Ferrajoli A, Lanasa MC. Chronic lymphocytic leukemia in African Americans. Leuk Lymphoma. 2012;53:2326–9.

Article  PubMed  Google Scholar 

Shenoy PJ, Malik N, Sinha R, Nooka A, Nastoupil LJ, Smith M, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011;11:498–506.

Article  PubMed  Google Scholar 

Puente XS, Beà S, Valdés-Mas R, Villamor N, Gutiérrez-Abril J, Martín-Subero JI, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526:519–24.

Article  CAS  PubMed  Google Scholar 

Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brieghel C, da Cunha-Bang C, Yde CW, Schmidt AY, Kinalis S, Nadeu F, et al. The number of signaling pathways altered by driver mutations in chronic lymphocytic leukemia impacts disease outcome. Clin Cancer Res. 2020;26:1507–15.

Article  CAS  PubMed  Google Scholar 

Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, et al. Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nat Genet. 2022;54:1664–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robbe P, Ridout KE, Vavoulis DV, Dréau H, Kinnersley B, Denny N, et al. Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nat Genet. 2022;54:1675–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleinstern G, O’Brien DR, Li X, Tian S, Kabat BF, Rabe KG, et al. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index. Am J Hematol. 2020;95:906–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu L, Kim HT, Kasar SN, Benien P, Du W, Hoang K, et al. Survival of Del17p CLL depends on genomic complexity and somatic mutation. Clin Cancer Res. 2017;23:735–45.

Article  CAS  PubMed  Google Scholar 

Leeksma AC, Taylor J, Wu B, Gardner JR, He J, Nahas M, et al. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia. 2019;33:390–402.

Article  CAS  PubMed  Google Scholar 

Kleinstern G, Boddicker NJ, O’Brien DR, Allmer C, Rabe KG, Norman AD, et al. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood Adv. 2024;8:2118–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538:161–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiagge E, Jin DX, Newberg JY, Perea-Chamblee T, Pekala KR, Fong C, et al. Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer Cell. 2023;41:1963–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA. 2011. http://evs.gs.washington.edu/EVS/.

Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941–D947.

Article  CAS  PubMed  Google Scholar 

Kalari KR, Nair AA, Bhavsar JD, O’Brien DR, Davila JI, Bockol MA, et al. MAP-RSeq: Mayo analysis pipeline for RNA sequencing. BMC Bioinformatics. 2014;15:224–34.

Article  PubMed  PubMed Central  Google Scholar 

Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.

Article  CAS  PubMed  Google Scholar 

Liao Y, Smyth G, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 20